STING1 and diabetic cardiomyopathy: Notably, activation of TBK1 and its upstream cyclic GMP-AMP synthase–stimulator of interferon gene (cGAS-STING) pathway has been confirmed in diabetic cardiomyopathy and pharmacologically inhibited STING could effectively reduce its inflammation-related damage and pyroptosis [18].